These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 30943913

  • 1. Serum klotho is inversely associated with metabolic syndrome in chronic kidney disease: results from the KNOW-CKD study.
    Kim HJ, Lee J, Chae DW, Lee KB, Sung SA, Yoo TH, Han SH, Ahn C, Oh KH.
    BMC Nephrol; 2019 Apr 03; 20(1):119. PubMed ID: 30943913
    [Abstract] [Full Text] [Related]

  • 2. The association between soluble klotho and cardiovascular parameters in chronic kidney disease: results from the KNOW-CKD study.
    Kim HJ, Kang E, Oh YK, Kim YH, Han SH, Yoo TH, Chae DW, Lee J, Ahn C, Oh KH.
    BMC Nephrol; 2018 Mar 05; 19(1):51. PubMed ID: 29506503
    [Abstract] [Full Text] [Related]

  • 3. Circulating α-klotho levels in CKD and relationship to progression.
    Kim HR, Nam BY, Kim DW, Kang MW, Han JH, Lee MJ, Shin DH, Doh FM, Koo HM, Ko KI, Kim CH, Oh HJ, Yoo TH, Kang SW, Han DS, Han SH.
    Am J Kidney Dis; 2013 Jun 05; 61(6):899-909. PubMed ID: 23540260
    [Abstract] [Full Text] [Related]

  • 4. [Decreased Serum Levels of Klotho Protein in Chronic Kidney Disease Patients: Clinical Imortance].
    Milovanova LY, Mukhin NA, Kozlovskaya LV, Milovanov YS, Kiyakbaev GG, Rogova IV, Lebedeva MV, Androsova TV, Milovanova SY, Gil AY, Taranova MV.
    Vestn Ross Akad Med Nauk; 2016 Jun 05; 71(4):288-96. PubMed ID: 29297646
    [Abstract] [Full Text] [Related]

  • 5. Characteristics of urinary and serum soluble Klotho protein in patients with different degrees of chronic kidney disease.
    Akimoto T, Yoshizawa H, Watanabe Y, Numata A, Yamazaki T, Takeshima E, Iwazu K, Komada T, Otani N, Morishita Y, Ito C, Shiizaki K, Ando Y, Muto S, Kuro-o M, Kusano E.
    BMC Nephrol; 2012 Nov 23; 13():155. PubMed ID: 23176706
    [Abstract] [Full Text] [Related]

  • 6. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].
    Milovanova LY, Milovanov YS, Kudryavtseva DV, Markina MM, Milovanova SY, Kozlovskaya LV, Lebedeva MV, Beketov VD, Moiseev SV, Mukhin NA, Fomin VV, Svistunov AA.
    Ter Arkh; 2015 Nov 23; 87(6):10-16. PubMed ID: 26281189
    [Abstract] [Full Text] [Related]

  • 7. In chronic kidney disease, serum α-Klotho is related to serum bicarbonate and proteinuria.
    Hage V, Pelletier S, Dubourg L, Drai J, Cuerq C, Lemoine S, Hadj-Aissa A, Laville M, Fouque D.
    J Ren Nutr; 2014 Nov 23; 24(6):390-4. PubMed ID: 25193108
    [Abstract] [Full Text] [Related]

  • 8. The association between serum soluble Klotho and chronic kidney disease among us adults ages 40 to 79 years: Cross-sectional study.
    Zhang Z, Zhou X, Deng L, Jin K, Xiong X, Su X, Qiu S, Yang L.
    Front Public Health; 2022 Nov 23; 10():995314. PubMed ID: 36276390
    [Abstract] [Full Text] [Related]

  • 9. Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis.
    Shimamura Y, Hamada K, Inoue K, Ogata K, Ishihara M, Kagawa T, Inoue M, Fujimoto S, Ikebe M, Yuasa K, Yamanaka S, Sugiura T, Terada Y.
    Clin Exp Nephrol; 2012 Oct 23; 16(5):722-9. PubMed ID: 22457086
    [Abstract] [Full Text] [Related]

  • 10. Influence of exogenous growth hormone administration on circulating concentrations of α-klotho in healthy and chronic kidney disease subjects: a prospective, single-center open case-control pilot study.
    Adema AY, de Roij van Zuijdewijn CLM, Hoenderop JG, de Borst MH, Ter Wee PM, Heijboer AC, Vervloet MG, NIGRAM consortium,.
    BMC Nephrol; 2018 Nov 15; 19(1):327. PubMed ID: 30442108
    [Abstract] [Full Text] [Related]

  • 11. Dysmetabolic markers predict outcomes in autosomal dominant polycystic kidney disease.
    Kocyigit I, Ozturk F, Eroglu E, Karaca Z, Kaynar AS, Cetin M, Tokgoz B, Sipahioglu MH, Bayramov R, Sen A, Oymak O, Ecder T, Axelsson J.
    Clin Exp Nephrol; 2019 Sep 15; 23(9):1130-1140. PubMed ID: 31134465
    [Abstract] [Full Text] [Related]

  • 12. Serum klotho levels in acute kidney injury
.
    Seibert E, Radler D, Ulrich C, Hanika S, Fiedler R, Girndt M.
    Clin Nephrol; 2017 Apr 15; 87 (2017)(4):173-179. PubMed ID: 28157067
    [Abstract] [Full Text] [Related]

  • 13. Plasma s-Klotho is related to kidney function and predicts adverse renal outcomes in patients with advanced chronic kidney disease.
    Liu QF, Ye JM, Yu LX, He AL, Sun Q, He DW, Li SS.
    J Investig Med; 2018 Mar 15; 66(3):669-675. PubMed ID: 29061648
    [Abstract] [Full Text] [Related]

  • 14. [Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with Stages 3B-4 chronic kidney disease: A new direction of cardionephroprotection].
    Milovanov YS, Mukhin NA, Kozlovskaya LV, Milovanova SY, Markina MM.
    Ter Arkh; 2016 Mar 15; 88(6):21-25. PubMed ID: 27296257
    [Abstract] [Full Text] [Related]

  • 15. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I, Jaeger P, Ebner L, Wagner CA, Petzold K, Spichtig D, Poster D, Wüthrich RP, Russmann S, Serra AL.
    Nephrol Dial Transplant; 2013 Feb 15; 28(2):352-9. PubMed ID: 23129826
    [Abstract] [Full Text] [Related]

  • 16. Fibroblast Growth Factor 23 and α-Klotho Protein Are Associated with Adverse Clinical Outcomes in Non-Dialysis CKD Patients.
    Manou E, Thodis E, Arsos G, Pasadakis P, Panagoutsos S, Papadopoulou D, Papagianni A.
    Kidney Blood Press Res; 2020 Feb 15; 45(6):900-915. PubMed ID: 33040068
    [Abstract] [Full Text] [Related]

  • 17. Mediation of the relationship between proteinuria and serum phosphate: Insight from the KNOW-CKD study.
    Jung JY, Ro H, Chang JH, Kim AJ, Lee HH, Han SH, Yoo TH, Lee KB, Kim YH, Kim SW, Park SK, Chae DW, Oh KH, Ahn C, Chung W.
    PLoS One; 2020 Feb 15; 15(6):e0235077. PubMed ID: 32569271
    [Abstract] [Full Text] [Related]

  • 18. Relationship between cFGF23/Klotho ratio and phosphate levels in patients with chronic kidney disease.
    Liu Z, Zhou H, Chen X, Chen H, Wang Y, Wang T, Cai L, Hong Y, Ke H, Zheng J.
    Int Urol Nephrol; 2019 Mar 15; 51(3):503-507. PubMed ID: 30689182
    [Abstract] [Full Text] [Related]

  • 19. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
    Tranæus Lindblad Y, Olauson H, Vavilis G, Hammar U, Herthelius M, Axelsson J, Bárány P.
    Pediatr Nephrol; 2018 Jan 15; 33(1):147-157. PubMed ID: 28795324
    [Abstract] [Full Text] [Related]

  • 20. [Significance of the morphogenetic proteins FGF-23 and Klotho as predictors of prognosis of chronic kidney disease].
    Milovanova LIu, Milovanov IuS, Kozlovskaia LV, Mukhin NA.
    Ter Arkh; 2014 Jan 15; 86(4):36-44. PubMed ID: 24864466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.